Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
IPO News

| More

Anupam Rasayan India Limited IPO of Equity Shares to open on Friday, March 12, 2021

Posted On: 2021-03-08 06:00:41 (Time Zone: Arizona, USA)


Surat based, custom synthesis and manufacturing focused specialty chemicals company Anupam Rasayan India Limited("Company" or "Anupam Rasayan"), will open the Bid/Issue period in relation to its initial public offering of Equity Shares (the "Issue"/ "IPO") on Friday, March 12, 2021 and close on Tuesday, March 16, 2021. The price band for the Offer has been decided at Rs. 553.00 - Rs. 555.00 per Equity Share. The Company may, in consultation with the book running lead managers (the "BRLMs"), consider participation by Anchor Investors which shall be one Working Day prior to the Bid / Issue open Date, i.e. Wednesday, March 10, 2021.

- Price Band of Rs. 553.00 - Rs. 555.00 per equity share of face value of Rs. 10 each of Anupam Rasayan India Limited ("Equity Share")

- Bid/Issue Opening Date - Friday, March 12, 2021 and Bid/Issue Closing Date - Tuesday, March 16, 2021

- Minimum Bid Lot is 27 Equity Shares and in multiples of 27 Equity Shares thereafter

- The Floor Price is 55.30 times the face value of the Equity Shares and the Cap Price is 55.50 times the face value of the Equity Shares.

The Issue aggregating up to Rs. 7,600 million comprises a complete fresh issuance of Equity Shares, and will be listed on BSE Limited ("BSE") and the National Stock Exchange of India Limited ("NSE"). The Company proposes to utilise the Net Proceeds towards repayment/prepayment of certain indebtedness availed by the Company and for general corporate purposes.

Anupam Rasayan is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India (Source: "Independent Market Report on Crop Protection, Pharmaceuticals and Custom Synthesis" dated December 14, 2020 (the "F&S Report") prepared and released by Frost and Sullivan and commissioned and paid by the Company in connection with the Issue). The Company has two distinct verticals which includes life science related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals; and other specialty chemicals, comprising specialty pigment and dyes, and polymer additives. Anupam Rasayan has developed strong and long-term relationships with various multinational corporations, including Syngenta Asia Pacific Pte. Ltd., Sumitomo Chemical Company Limited and UPL Limited that has helped the Company expand its product offerings and geographic reach across Europe, Japan, United States and India. As of December 31, 2020, the Company operates through six multi-purpose manufacturing facilities based in Gujarat, India; with four facilities located at Sachin, Surat, Gujarat and two located at Jhagadia, Bharuch, Gujarat.

From FY18 to FY20, the Company's total revenue has increased at a CAGR of 24.29 % and its EBITDA for FY20 stood at ₹ 1,348.96 million all of our facilities restarted operations, subject to certain adjustments in working patterns and limited workforce. Despite the impact of the COVID-19 pandemic, the Company's revenue from operations significantly increased by 45.03% from ₹ 3,718.07 million in the nine months ended December 31, 2019 to ₹ 5,392.20 million in the nine months ended December 31, 2020.

Axis Capital Limited, Ambit Private Limited, IIFL Securities Limited and JM Financial Limited are the book running lead managers to the Issue ("BRLMs").

The Issue is being made through the Book Building Process, in compliance with Regulation 6(1) of the SEBI ICDR Regulations, where not more than 50% of the Net Issue shall be available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBs") (the "QIB Category"), provided that the Company in consultation with the BRLMs, may allocate up to 60% of the QIB Category to Anchor Investors, on a discretionary basis (the "Anchor Investor Portion"), of which one-third shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the price at which Equity Shares are allocated to Anchor Investors. In the event of under-subscription or non-allocation in the Anchor Investor Portion, the balance Equity Shares shall be added to the QIB Category (other than Anchor Investor Portion). Further, 5% of the QIB Category (excluding the Anchor Investor Portion) shall be available for allocation on a proportionate basis to Mutual Funds only and the remainder of the QIB Category shall be available for allocation on a proportionate basis to all QIBs, including Mutual Funds, subject to valid Bids being received at or above the Issue Price.

Note: Capitalized terms used and not defined herein shall have the respective meanings ascribed to them in the red herring prospectus dated March 5, 2021 of the Company.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

Paras Defence raises Rs. 51 crores from Anchor Investors

Defence and Space Tech Co, Paras becomes most oversubscribed IPO in Capital Markets History

Hyderabad based Consumer Durable Retail Chain, Electronics Mart India files for Rs 500 cr IPO

Hyderabad based Hariom Pipe files for Rs 120 crore IPO

Florintree backed Defence Electronics Co. Data Patterns files for IPO

Paras Defence and Space Technologies Limited's IPO to open on September 21, 2021

Kolkata based Metal and Mining Co., Tega Industries files for its IPO

Prudent Corporate Advisory Services Limited files DRHP with SEBI

Private Market Intelligence SaaS Platform, Tracxn files for an IPO

Inspira Enterprise India Limited files DRHP with SEBI

Aptus Value Housing Finance India Limited, Issue subscribed 0.37 times, Retail portion booked 0.54 times on day 2

Nuvoco's IPO final day: Issue subscribed 1.71 times on final day, Best interest from QIB subscribed 4.23 times

Keventer Agro Limited files DRHP with SEBI

Aptus Value Housing Finance India Limited raises Rs. 834 crs from 21 Anchor Investors

Retail Segment laps up 80 % of CarTrade's IPO on Day 1

Nuvoco sees Steady Retail Category Interest 31% Subscribed on Day 1

Hyderabad based Edible Oil Co., Gemini Edibles & Fats files for Rs. 2500 cr IPO

Nuvoco Vistas raises Rs. 1,500 crores from Anchor Investors, 30% of the IPO size of Rs. 5,000 crores

Exxaro Tiles Limited IPO final day: Issue subscribed 22.57 times, Best interest from Retail investors subscribed 39.88 times

Devyani International Limited IPO Final Day: Issue subscribed 116.71 times, Retail portion booked 39.51

Devyani International Limited Issue subscribed 6.61 times, Retail portion booked 22.94 on day 2

Exxaro Tiles Limited IPO subscribed 10. 30 times, Retail portion booked 21.11 times on day 2

Chemplast Sanmar Limited Initial Public Offer to open on Tuesday, August 10, 2021

Aptus Value Housing Finance India Limited's IPO to open on August 10, 2021

Devyani International Limited Issue subscribed 2.69 times, Retail portion booked 11.36 times on day 1

Exxaro Tiles Limited Issue subscribed 4.67 times, Retail portion booked 9.29 times on day 1

Nuvoco Vistas's Rs. 5,000 crores IPO to open on August 09, 2021

FSN E-Commerce Ventures Private Limited (Nykaa) Files DRHP with SEBI for IPO

Profitable Multi-Channel Auto Platform CarTrade Tech Limited's IPO to open on August 09, 2021

Krsnaa Diagnostics Limited IPO to open on August 4, 2021

Fino Payments Bank becomes the first profitable fintech to file for an IPO

Devyani International Limited's IPO to open on August 04, 2021

Vitrified Tiles Major, Exxaro Tiles Limited's IPO to open on August 04, 2021

Windlas Biotech Limited Initial Public Offer to open on Wednesday, August 04, 2021

ESAF Small Finance Bank files for Rs 998 cr IPO

CarTrade Tech Limited gets SEBI approval to float Rs. 2000 crore IPO

Retail focused HFC, Aptus Value Housing gets SEBI approval for IPO

Glenmark Life Sciences IPO - Top Things to Know

Anand Rathi Wealth Ltd files for Rs 1000 cr IPO

Glenmark Life Sciences Limited IPO to open on July 27, 2021

QSR Player Devyani International gets SEBI approval for IPO

Nuvoco Vistas Corporation Limited gets SEBI approval to float Rs. 5000 crore IPO

Northern Arc Capital Limited plans for IPO files DRHP with SEBI

IPO-Bound Veeda Clinical Research acquires majority stake in Bioneeds preclinical

India's Leading Digital Ecosystem, Paytm files for Rs. 16,600 Crore IPO

Chemspec Chemicals Limited plans for IPO files DRHP with SEBI

Tatva Chintan Pharma Chem Initial Public Offer to open on July 16, 2021

G R Infraprojects Limited IPO oversubscribed by over 100 times

G R Infraprojects Limited Issue subscribed 5.90 times, Retail portion booked 7.49 times on day 2

Zomato Limited IPO to open on July 14, 2021


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020